Volker Liebenberg
Overview
Explore the profile of Volker Liebenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
1139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schmidt B, Beyer J, Dietrich D, Bork I, Liebenberg V, Fleischhacker M
PLoS One
. 2015 Feb;
10(2):e0118195.
PMID: 25675432
Purpose: Most patients suffering from advanced lung cancer die within a few months. To exploit new therapy regimens we need better methods for the assessment of a therapy response. Material...
2.
Nikiforova V, Giesbertz P, Wiemer J, Bethan B, Looser R, Liebenberg V, et al.
J Diabetes Res
. 2014 Dec;
2014:685204.
PMID: 25525609
Type 2 diabetes (T2D) is characterized by a variety of metabolic impairments that are closely linked to nonenzymatic glycation reactions of proteins and peptides resulting in advanced glycation end-products (AGEs)....
3.
Padberg I, Peter E, Gonzalez-Maldonado S, Witt H, Mueller M, Weis T, et al.
PLoS One
. 2014 Jan;
9(1):e85082.
PMID: 24465478
Objective: The objective of the current study was to find a metabolic signature associated with the early manifestations of type-2 diabetes mellitus. Research Design And Method: Modern metabolic profiling technology...
4.
Kamlage B, Gonzalez Maldonado S, Bethan B, Peter E, Schmitz O, Liebenberg V, et al.
Clin Chem
. 2013 Dec;
60(2):399-412.
PMID: 24305685
Background: Metabolomics is a valuable tool with applications in almost all life science areas. There is an increasing awareness of the essential need for high-quality biospecimens in studies applying omics...
5.
Fleischhacker M, Dietrich D, Liebenberg V, Field J, Schmidt B
Expert Rev Respir Med
. 2013 Aug;
7(4):363-83.
PMID: 23964627
It is now widely accepted that cancer is caused by complex interactions between genetic and epigenetic factors and the environment. Only in the last 20 years, DNA methylation has been...
6.
Dietrich D, Hasinger O, Liebenberg V, Field J, Kristiansen G, Soltermann A
Diagn Mol Pathol
. 2012 May;
21(2):93-104.
PMID: 22555092
Biomarkers that facilitate prediction of disease progression in lung cancer patients might be clinically valuable in optimizing individualized therapy. In this study, the ability of the DNA methylation biomarkers PITX2...
7.
Dietrich D, Kneip C, Raji O, Liloglou T, Seegebarth A, Schlegel T, et al.
Int J Oncol
. 2011 Nov;
40(3):825-32.
PMID: 22108652
In the identification of subjects with lung cancer, increased DNA methylation of the SHOX2 gene locus in bronchial aspirates has previously been proven to be a clinically valuable biomarker. This...
8.
Kneip C, Schmidt B, Seegebarth A, Weickmann S, Fleischhacker M, Liebenberg V, et al.
J Thorac Oncol
. 2011 Jun;
6(10):1632-8.
PMID: 21694641
Introduction: Recently, analysis of DNA methylation of the SHOX2 locus was shown to reliably identify lung cancer in bronchial aspirates of patients with disease. As a plasma-based assay would expand...
9.
Schneider K, Dietrich D, Fleischhacker M, Leschber G, Merk J, Schaper F, et al.
BMC Cancer
. 2011 Mar;
11:102.
PMID: 21426551
Background: DNA methylation in the SHOX2 locus was previously used to reliably detect lung cancer in a group of critical controls, including 'cytologically negative' samples with no visible tumor cell...
10.
Schmidt B, Liebenberg V, Dietrich D, Schlegel T, Kneip C, Seegebarth A, et al.
BMC Cancer
. 2010 Nov;
10:600.
PMID: 21047392
Background: This study aimed to show that SHOX2 DNA methylation is a tumor marker in patients with suspected lung cancer by using bronchial fluid aspirated during bronchoscopy. Such a biomarker...